Cargando…
The rcdk and cluster R packages applied to drug candidate selection
The aim of this article is to show how thevpower of statistics and cheminformatics can be combined, in R, using two packages: rcdk and cluster. We describe the role of clustering methods for identifying similar structures in a group of 23 molecules according to their fingerprints. The most commonly...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970292/ https://www.ncbi.nlm.nih.gov/pubmed/33430987 http://dx.doi.org/10.1186/s13321-019-0405-0 |
_version_ | 1783489490661146624 |
---|---|
author | Voicu, Adrian Duteanu, Narcis Voicu, Mirela Vlad, Daliborca Dumitrascu, Victor |
author_facet | Voicu, Adrian Duteanu, Narcis Voicu, Mirela Vlad, Daliborca Dumitrascu, Victor |
author_sort | Voicu, Adrian |
collection | PubMed |
description | The aim of this article is to show how thevpower of statistics and cheminformatics can be combined, in R, using two packages: rcdk and cluster. We describe the role of clustering methods for identifying similar structures in a group of 23 molecules according to their fingerprints. The most commonly used method is to group the molecules using a “score” obtained by measuring the average distance between them. This score reflects the similarity/non-similarity between compounds and helps us identify active or potentially toxic substances through predictive studies. Clustering is the process by which the common characteristics of a particular class of compounds are identified. For clustering applications, we are generally measure the molecular fingerprint similarity with the Tanimoto coefficient. Based on the molecular fingerprints, we calculated the molecular distances between the methotrexate molecule and the other 23 molecules in the group, and organized them into a matrix. According to the molecular distances and Ward ’s method, the molecules were grouped into 3 clusters. We can presume structural similarity between the compounds and their locations in the cluster map. Because only 5 molecules were included in the methotrexate cluster, we considered that they might have similar properties and might be further tested as potential drug candidates. |
format | Online Article Text |
id | pubmed-6970292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-69702922020-01-27 The rcdk and cluster R packages applied to drug candidate selection Voicu, Adrian Duteanu, Narcis Voicu, Mirela Vlad, Daliborca Dumitrascu, Victor J Cheminform Educational The aim of this article is to show how thevpower of statistics and cheminformatics can be combined, in R, using two packages: rcdk and cluster. We describe the role of clustering methods for identifying similar structures in a group of 23 molecules according to their fingerprints. The most commonly used method is to group the molecules using a “score” obtained by measuring the average distance between them. This score reflects the similarity/non-similarity between compounds and helps us identify active or potentially toxic substances through predictive studies. Clustering is the process by which the common characteristics of a particular class of compounds are identified. For clustering applications, we are generally measure the molecular fingerprint similarity with the Tanimoto coefficient. Based on the molecular fingerprints, we calculated the molecular distances between the methotrexate molecule and the other 23 molecules in the group, and organized them into a matrix. According to the molecular distances and Ward ’s method, the molecules were grouped into 3 clusters. We can presume structural similarity between the compounds and their locations in the cluster map. Because only 5 molecules were included in the methotrexate cluster, we considered that they might have similar properties and might be further tested as potential drug candidates. Springer International Publishing 2020-01-20 /pmc/articles/PMC6970292/ /pubmed/33430987 http://dx.doi.org/10.1186/s13321-019-0405-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Educational Voicu, Adrian Duteanu, Narcis Voicu, Mirela Vlad, Daliborca Dumitrascu, Victor The rcdk and cluster R packages applied to drug candidate selection |
title | The rcdk and cluster R packages applied to drug candidate selection |
title_full | The rcdk and cluster R packages applied to drug candidate selection |
title_fullStr | The rcdk and cluster R packages applied to drug candidate selection |
title_full_unstemmed | The rcdk and cluster R packages applied to drug candidate selection |
title_short | The rcdk and cluster R packages applied to drug candidate selection |
title_sort | rcdk and cluster r packages applied to drug candidate selection |
topic | Educational |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970292/ https://www.ncbi.nlm.nih.gov/pubmed/33430987 http://dx.doi.org/10.1186/s13321-019-0405-0 |
work_keys_str_mv | AT voicuadrian thercdkandclusterrpackagesappliedtodrugcandidateselection AT duteanunarcis thercdkandclusterrpackagesappliedtodrugcandidateselection AT voicumirela thercdkandclusterrpackagesappliedtodrugcandidateselection AT vladdaliborca thercdkandclusterrpackagesappliedtodrugcandidateselection AT dumitrascuvictor thercdkandclusterrpackagesappliedtodrugcandidateselection AT voicuadrian rcdkandclusterrpackagesappliedtodrugcandidateselection AT duteanunarcis rcdkandclusterrpackagesappliedtodrugcandidateselection AT voicumirela rcdkandclusterrpackagesappliedtodrugcandidateselection AT vladdaliborca rcdkandclusterrpackagesappliedtodrugcandidateselection AT dumitrascuvictor rcdkandclusterrpackagesappliedtodrugcandidateselection |